A carregar...
Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment
AIMS: To investigate whether the pharmacokinetic characteristics of semaglutide were altered in people with hepatic impairment, assessed using Child–Pugh criteria, vs those with normal hepatic function. METHODS: In this multicentre, open‐label, parallel‐group trial (sponsor Novo Nordisk, ClinicalTri...
Na minha lista:
| Publicado no: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5873441/ https://ncbi.nlm.nih.gov/pubmed/29205786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13186 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|